Among the 27 genes that were upregulated in GBM patients compared to normal human brain samples within the TCGA cohort, FN1 and TWIST1 were significant predictors of poorer overall survival based on the log-rank test (p < 0.05, Figure 5). The gene discussed is FN1; the disease is glioblastoma.